LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 65.12 | 17.25 | 5642 | 5095 | 1.1073 | 1.0250 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 67.09 | 17.25 | 16 | 5221 | 0.0031 | -0.0091 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 67.09 | 17.25 | 5296 | 5221 | 1.0144 | 1.0035 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 67.09 | 17.25 | 4682 | 5221 | 0.8968 | 0.9737 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 67.09 | 17.25 | 5152 | 5221 | 0.9868 | 0.9968 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 67.09 | 17.25 | 9 | 5221 | 0.0017 | -0.0759 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 67.09 | 17.25 | 5818 | 5221 | 1.1143 | 1.0264 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 69.06 | 17.25 | 31 | 5242 | 0.0059 | 0.0736 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 69.06 | 17.25 | 5536 | 5242 | 1.0560 | 1.0132 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 69.06 | 17.25 | 4957 | 5242 | 0.9455 | 0.9865 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 69.06 | 17.25 | 5332 | 5242 | 1.0170 | 1.0041 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 69.06 | 17.25 | 15 | 5242 | 0.0029 | -0.0168 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 69.06 | 17.25 | 6059 | 5242 | 1.1557 | 1.0354 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 71.03 | 17.25 | 25 | 5367 | 0.0047 | 0.0458 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 71.03 | 17.25 | 5718 | 5367 | 1.0654 | 1.0154 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 71.03 | 17.25 | 5141 | 5367 | 0.9579 | 0.9896 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 71.03 | 17.25 | 5533 | 5367 | 1.0309 | 1.0074 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 71.03 | 17.25 | 7 | 5367 | 0.0013 | -0.1032 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 71.03 | 17.25 | 6262 | 5367 | 1.1667 | 1.0376 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 73.00 | 17.25 | 47 | 5546 | 0.0085 | 0.1279 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 73.00 | 17.25 | 6039 | 5546 | 1.0887 | 1.0205 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 73.00 | 17.25 | 5043 | 5546 | 0.9092 | 0.9773 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 73.00 | 17.25 | 5779 | 5546 | 1.0419 | 1.0099 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 73.00 | 17.25 | 14 | 5546 | 0.0025 | -0.0248 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 73.00 | 17.25 | 6521 | 5546 | 1.1756 | 1.0392 | MN20160310_N02 | N12 |